Ty A. Ridenour

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter

Filter by Type

Filter by Year

Search Results

RTI Center for Behavioral Health Epidemiology, Implementation, and Evaluation Research

Transitioning from DSM-IV abuse to dependence: The essence of harmful compulsive substance use is ontogenetic and dynamic

Does DSM-5 nomenclature for inhalant use disorder improve upon DSM-IV?

Illustrating idiographic methods for translation research: moderation effects, natural clinical experiments, and complex treatment-by-subgroup interactions

Potential utility of idiographic clinical trials in drug development

Toward idiographic research in prevention science: Demonstration of three techniques for rigorous small sample research

Webinar: Leveraging Social Environment in the Prevention of Opioid Use Disorder

Precision strategies as a timely and unifying framework for ongoing prevention science advances

Barriers and facilitators for a well-child screening and brief intervention to prevent substance abuse

Detecting risk for substance use before high school during pediatric well-child check-ups

The clinical trials mosaic: Toward a range of clinical trials designs to optimize evidence-based treatment

N=1 statistical approaches to examine within-individual risk factor profiles of ICHD-3beta classified migraines versus non-migraine headaches

Recent advances and illustrations of modern with-in-subjects clinical trials methods

Society for Prevention Research 2023 Annual Meeting

Geographic clustering of and effect of barriers on neurobehavior disinhibition risk for substance use disorder: implications for neighborhood-level prevention strategy

N=1 statistical approaches to examine risk factor profiles of ICHD-3beta classified migraines within individuals.